Login
$AEMD
$5.15 +$0.10 (1.98%) Close

$AEMD SEC Filings

Filed On Filing
15 Oct 2026 Form 4: Larosa Steven P, Chief Medical Officer

Received 42,000 shares as a grant or award

15 Oct 2026 Form 4: Shah Chetan, Director

Gave up 436 shares to cover exercise price or tax ($2.84K)

15 Oct 2026 Form 4/A: Rossetti Angela, Director

Received 21,815 shares as a grant or award ($50K)

15 Oct 2026 Form 4: Gikakis Nicolas, Director

Gave up 436 shares to cover exercise price or tax ($2.84K)

15 Oct 2026 Form 4: Broenniman Edward G, Director

Gave up 218 shares to cover exercise price or tax ($1.42K)

13 Oct 2026 Form 4: Frakes James B, Director

Received 42,000 shares as a grant or award

13 Oct 2026 SCHEDULE 13G
09 Oct 2026 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Record Nurrnber Fllecl In the Office af C3159 - 1991 f'Jlff ೦ FlUng - Numberrrom: 1v1arr. 1 - 111 F202610081657 FUecl Oil Secretary of State State Of Nevada 10/0812026 12•53 PM Number of Pages 2 r - ·· - 12: - :fo:ss i:i.m.10 ೦ 01 - 2020...

05 Oct 2026 8-K/A: Submission of Matters to a Vote of Security Holders

Proposal No. 7: The Company’s stockholders did not approve a proposed amendment to the Company's Articles of Incorporation to authorize 20,000,000 shares of preferred stock, par value $0.001 per share, and authorize the Board of Director...

01 Oct 2026 8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Submission of Matters to a Vote of Security Holders

(a) Successor to and Continuation of Prior Plan. The Plan is the successor to and continuation of the Prior Plan. As of the Effective Date, (i) no additional awards may be granted under the Prior Plan; (ii) the Prior Plan’s Available Res...

17 Sep 2026 FORM 8-K
17 Sep 2026 8-K: Entry into a Material Definitive Agreement; Changes in Control of Registrant +1 more

First Certificate of Merger, including certificate of incorporation of the First Step Surviving Corporation attached as Exhibit A thereto, incorporated by reference into this Agreement

15 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

This Amendment No. 2 to Executive Employment Agreement (this “Amendment”) is made and entered into as of September 11, 2026 (the “Amendment Effective Date”), by and between James B. Frakes (“Employee”) and Aethlon Medical, Inc., a Nevada...

04 Sep 2026 FORM DEFA14A
01 Sep 2026 Proxy statement: annual meeting on October 1, 2026

CEO pay $827K, up 65% · say-on-pay vote

31 Aug 2026 8-K: Other Events
21 Aug 2026 PRELIMINARY PROXY STATEMENT
13 Aug 2026 FORM 10-Q FOR JUN 2026
13 Aug 2026 SCHEDULE 13G/A
13 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support